Wellington Management Group LLP Acquires 66,075 Shares of Teleflex Incorporated (NYSE:TFX)

Wellington Management Group LLP increased its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 42.0% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 223,438 shares of the medical technology company's stock after buying an additional 66,075 shares during the period. Wellington Management Group LLP owned 0.48% of Teleflex worth $39,767,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. State Street Corp lifted its stake in shares of Teleflex by 1.0% in the third quarter. State Street Corp now owns 2,057,080 shares of the medical technology company's stock worth $508,757,000 after buying an additional 21,291 shares in the last quarter. Geode Capital Management LLC lifted its position in Teleflex by 0.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company's stock valued at $278,676,000 after acquiring an additional 5,746 shares in the last quarter. Cooke & Bieler LP lifted its position in Teleflex by 22.1% in the 4th quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company's stock valued at $191,962,000 after acquiring an additional 195,150 shares in the last quarter. Norges Bank bought a new stake in shares of Teleflex in the 4th quarter worth $100,328,000. Finally, Magnetar Financial LLC increased its holdings in shares of Teleflex by 105.2% in the 4th quarter. Magnetar Financial LLC now owns 421,340 shares of the medical technology company's stock worth $74,990,000 after purchasing an additional 215,961 shares in the last quarter. Institutional investors own 95.62% of the company's stock.

Teleflex Stock Performance

Teleflex stock traded up $0.74 during trading on Friday, reaching $129.81. The company had a trading volume of 642,249 shares, compared to its average volume of 614,950. The firm has a market capitalization of $6.02 billion, a price-to-earnings ratio of 25.81, a price-to-earnings-growth ratio of 1.73 and a beta of 1.19. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The firm's 50-day simple moving average is $148.00 and its 200 day simple moving average is $181.53. Teleflex Incorporated has a 52 week low of $124.66 and a 52 week high of $249.91.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping the consensus estimate of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm had revenue of $795.40 million for the quarter, compared to the consensus estimate of $813.24 million. Sell-side analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were paid a $0.34 dividend. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.05%. Teleflex's dividend payout ratio (DPR) is presently 95.77%.

Analyst Ratings Changes

Several research firms recently commented on TFX. Piper Sandler reaffirmed a "neutral" rating and set a $140.00 price objective (down from $255.00) on shares of Teleflex in a research report on Friday, February 28th. Bank of America lowered shares of Teleflex from a "neutral" rating to an "underperform" rating and reduced their price target for the stock from $235.00 to $140.00 in a research note on Tuesday, March 4th. Truist Financial decreased their price objective on shares of Teleflex from $149.00 to $140.00 and set a "hold" rating for the company in a report on Friday. StockNews.com cut shares of Teleflex from a "buy" rating to a "hold" rating in a report on Friday, February 28th. Finally, Morgan Stanley decreased their target price on shares of Teleflex from $275.00 to $191.00 and set an "overweight" rating for the company in a research note on Wednesday, March 5th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, Teleflex presently has an average rating of "Hold" and a consensus price target of $181.50.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.